Health
65 Equity Makes Europe Foray With Swiss Pharma Merger
This article is for subscribers only.
Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s acquisition of Cerbios-Pharma SA, marking its first deal in Europe.
The investor, backed by by Singapore’s Temasek Holdings Pte, is financing HAS’s acquisition of Cerbios and will become a shareholder with about a 40% stake in the merged entity, according to a statement reviewed by Bloomberg News. The Braglia family, which used to fully own HAS, will own the remainder of the new firm, with Cerbios holders selling out.